Glenmark Pharmaceuticals informs about press release

15 Sep 2015 Evaluate

Glenmark Pharmaceuticals has informed regarding a Press Release dated September 15, 2015 titled ‘Glenmarks Bi-Specific Antibody - GBR 1302 to enter Phase I trials’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1989.30 -11.75 (-0.59%)
28-Jan-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1615.05
Dr. Reddys Lab 1225.70
Cipla 1318.65
Zydus Lifesciences 890.85
Lupin 2127.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×